| Literature DB >> 32409787 |
Karina Barsunova1, Marko Vendelin1, Rikke Birkedal2.
Abstract
Creatine kinase (CK) functions as an energy buffer in muscles. Its substrate, creatine, is generated by L-arginine:glycine amidinotransferase (AGAT) and guanidinoacetate N-methyltransferase (GAMT). Creatine deficiency has more severe consequences for AGAT than GAMT KO mice. In the present study, to characterize their muscle phenotype further, we recorded the weight of tibialis anterior (TA), extensor digitorum longus (EDL), gastrocnemius (GAS), plantaris (PLA) and soleus (SOL) from creatine-deficient AGAT and GAMT, KO and WT mice. In GAS, PLA and SOL representing glycolytic, intermediate and oxidative muscle, respectively, we recorded the activities of pyruvate kinase (PK), lactate dehydrogenase (LDH), citrate synthase (CS) and cytochrome oxidase (CO). In AGAT KO compared to WT mice, muscle atrophy and differences in marker enzyme activities were more pronounced in glycolytic than oxidative muscle. In GAMT KO compared to WT, the atrophy was modest, differences in PK and LDH activities were minor, and CS and CO activities were slightly higher in all muscles. SOL from males had higher CS and CO activities compared to females. Our results add detail to the characterization of AGAT and GAMT KO skeletal muscle phenotypes and illustrate the importance of taking into account differences between muscles, and differences between sexes.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32409787 PMCID: PMC7224371 DOI: 10.1038/s41598-020-64740-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Body weight (BW), tibial length (TL) and age of AGAT and GAMT, WT and KO, males and females.
| AGAT | n | BW, g | TL, cm | Age, days |
|---|---|---|---|---|
| WT male | 7 | 33.0 ± 1.2 | 2.20 ± 0.02 | 199 ± 15 |
| KO male | 7 | 18.6 ± 0.4 | 2.10 ± 0.01 | 178 ± 9 |
| % of WT | 56 | 96 | ||
| WT female | 14 | 25.0 ± 0.8 | 2.17 ± 0.01 | 214 ± 13 |
| KO female | 7 | 15.4 ± 0.3 | 2.07 ± 0.02 | 217 ± 20 |
| % of WT | 62 | 95 | ||
| G | *** | *** | ||
| S | *** | |||
| Int | * | |||
| WT male | 7 | 34.4 ± 1.9 | 2.21 ± 0.02 | 190 ± 10 |
| KO male | 8 | 25.3 ± 0.8 | 2.16 ± 0.01 | 190 ± 10 |
| % of WT | 74 | 98 | ||
| WT female | 7 | 26.6 ± 0.6 | 2.18 ± 0.01 | 213 ± 21 |
| KO female | 6 | 20.0 ± 1.7 | 2.11 ± 0.01 | 187 ± 9 |
| % of WT | 75 | 97 | ||
| G | *** | *** | ||
| S | *** | |||
| Int | ||||
Values are shown as mean ± SEM. The effects of genotype (G; WT and KO), sex (S; male and female) and their interaction (Int) obtained by analysis with a two-way Bayesian Anova are shown below the data for each strain (AGAT and GAMT). Significance notation: *10 ≤ BF < 30 strong evidence; **30 ≤ BF < 100 very strong evidence; ***BF ≥ 100 extremely strong evidence.
Hindleg muscle weights in AGAT and GAMT, WT and KO, males and females.
| AGAT | n | Muscle weight, MW | ||||
|---|---|---|---|---|---|---|
| GAS, mg | PLA, mg | SOL, mg | TA, mg | EDL, mg | ||
| WT male | 7 | 142.1 ± 3.5 | 20.2 ± 0.4 | 10.5 ± 0.3 | 55.6 ± 0.9 | 11.8 ± 0.3 |
| KO male | 7 | 35.3 ± 2.0 | 6.7 ± 0.3 | 6.6 ± 0.3 | 16.8 ± 0.7 | 4.1 ± 0.2 |
| % of WT | 25 | 33 | 62 | 30 | 35 | |
| WT female | 14 | 111.5 ± 2.1 | 15.3 ± 0.4 | 8.3 ± 0.3 | 45.0 ± 0.9 | 9.3 ± 0.2 |
| KO female | 7 | 26.2 ± 1.4 | 5.4 ± 0.2 | 5.4 ± 0.2 | 13.1 ± 0.6 | 3.4 ± 0.1 |
| % of WT | 24 | 35 | 65 | 29 | 37 | |
| G | *** | *** | *** | *** | *** | |
| S | *** | *** | *** | *** | *** | |
| Int | *** | *** | *** | *** | ||
| WT male | 7 | 152.0 ± 5.9 | 21.2 ± 1.1 | 11.6 ± 0.7 | 56.3 ± 1.8 | 13.2 ± 0.8 |
| KO male | 8 | 104.2 ± 2.2 | 15.1 ± 0.4 | 7.9 ± 0.2 | 36.5 ± 1.1 | 7.6 ± 0.3 |
| % of WT | 69 | 71 | 68 | 65 | 58 | |
| WT female | 7 | 123.0 ± 2.9 | 17.3 ± 0.7 | 8.8 ± 0.3 | 46.1 ± 0.9 | 10.3 ± 0.3 |
| KO female | 6 | 78.3 ± 3.0 | 11.0 ± 0.4 | 6.6 ± 0.3 | 27.6 ± 1.2 | 5.9 ± 0.2 |
| % of WT | 64 | 64 | 75 | 60 | 57 | |
| G | *** | *** | *** | *** | *** | |
| S | *** | *** | *** | *** | *** | |
| Int | ||||||
Values are shown as mean ± SEM. Statistical analysis and notation is the same as in Table 1.
Hindleg muscle weights (MW) normalized to body weight (BW) in AGAT and GAMT, WT and KO, males and females.
| AGAT | n | Relative muscle weight, MW/BW | ||||
|---|---|---|---|---|---|---|
| GAS, mg/g | PLA, mg/g | SOL, mg/g | TA, mg/g | EDL, mg/g | ||
| WT male | 7 | 4.33 ± 0.18 | 0.62 ± 0.02 | 0.32 ± 0.02 | 1.69 ± 0.06 | 0.36 ± 0.01 |
| KO male | 7 | 1.90 ± 0.08 | 0.36 ± 0.04 | 0.35 ± 0.01 | 0.90 ± 0.03 | 0.22 ± 0.01 |
| % of WT | 44 | 58 | 110 | 53 | 62 | |
| WT female | 14 | 4.50 ± 0.12 | 0.62 ± 0.02 | 0.34 ± 0.01 | 1.84 ± 0.05 | 0.38 ± 0.01 |
| KO female | 7 | 1.70 ± 0.08 | 0.35 ± 0.01 | 0.35 ± 0.01 | 0.85 ± 0.04 | 0.22 ± 0.01 |
| % of WT | 38 | 57 | 105 | 46 | 59 | |
| G | *** | *** | *** | *** | ||
| S | ||||||
| Int | ||||||
| GAMT | ||||||
| WT male | 7 | 4.44 ± 0.17 | 0.62 ± 0.03 | 0.34 ± 0.02 | 1.66 ± 0.07 | 0.39 ± 0.02 |
| KO male | 8 | 4.13 ± 0.06 | 0.60 ± 0.01 | 0.31 ± 0.01 | 1.44 ± 0.02 | 0.30 ± 0.00 |
| % of WT | 93 | 97 | 93 | 87 | 77 | |
| WT female | 7 | 4.48 ± 0.18 | 0.62 ± 0.02 | 0.32 ± 0.01 | 1.68 ± 0.07 | 0.38 ± 0.02 |
| KO female | 6 | 3.94 ± 0.12 | 0.56 ± 0.02 | 0.33 ± 0.01 | 1.39 ± 0.07 | 0.30 ± 0.01 |
| % of WT | 88 | 89 | 104 | 81 | 79 | |
| Effect | ||||||
| G | *** | *** | ||||
| S | ||||||
| Int | ||||||
Values are shown as mean ± SEM. Statistical analysis and notation is the same as in Table 1.
Figure 1PK (a) and LDH (b) activity in GAS, PLA and SOL from AGAT and GAMT, WT and KO, males and females. The results are shown as box-and-whisker plots according to the Tukey notation as well as by individual datapoints (circles). Females are shown in orange and males are shown in turquoise. The numbers of experiments are the same as in the tables. Below each genotype for each muscle are the statistical results as determined by a two-way Bayesian Anova: the best fitting model and the significant factors within that model. G – effect of genotype (WT, KO); S – effect of sex (female, male). Significance notation: BF < 10 not significant (NS), 30 ≤ BF < 100 very strong evidence (**), and BF ≥ 100 extremely strong evidence (***).
Figure 2CS (a) and CO (b) activity in GAS, PLA and SOL from AGAT and GAMT, WT and KO, males and females. Notation is the same as in Fig. 1, and the numbers of experiments are the same as in the tables. Significance notation: 10 ≤ BF < 30 strong evidence (*), 30 ≤ BF < 100 very strong evidence (**), and BF ≥ 100 extremely strong evidence (***).